Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Plasma cell 1CNS 1

Conditions

Brain Neoplasms 2Neoplasms 1Lymphoma 1Leukemia 1Glioblastoma 1

Interventions

Psychiatric Rehabilitation 5Melphalan 5Cyclophosphamide 5Methylprednisolone 4Flow Cytometry 4Busulfan 4Early Intervention, Educational 3Antilymphocyte Serum 3Alemtuzumab 3fludarabine phosphate 2Radiotherapy 2Immunologic Techniques 2Filgrastim 2Azacitidine 2thymoglobulin 1tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1pembrolizumab 1neratinib 1ixabepilone 1fosphenytoin 1fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1bempegaldesleukin 1aldesleukin 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Educational Status × CNS × Clear all
NCT02505165 2022-04-13

IMPACT

Children's Hospital Medical Center, Cincinnati

Phase NA Completed
279 enrolled
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Leukemia, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡